Brought to you by 
Nimbus Discovery brings in $24mm in Series A funding
08 May 2013
Executive Summary
On the heels of a seed equity top-off four months ago, computational drug discovery start-up Nimbus Discovery LLC has now closed a $24mm Series A financing co-led by returning backer Atlas Venture and new investors SR One and Lilly Ventures. Existing investor Bill Gates (of Microsoft) also participated. Partners from SR One and Lilly Ventures joined the board.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- ADMET
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nimbus Discovery brings in $24mm in Series A funding
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice